CIDARA THERAPEUTICS, INC. Income (Loss) from Continuing Operations, Per Basic Share
CIDARA THERAPEUTICS, INC. reported Income (Loss) from Continuing Operations, Per Basic Share of -$3.10 per share for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerBasicShare · last filed 2025-11-06
- CIDARA THERAPEUTICS, INC. income (loss) from continuing operations, per basic share for the quarter ending 2025-09-30 was -$3.10.
- CIDARA THERAPEUTICS, INC. income (loss) from continuing operations, per basic share for the quarter ending 2025-06-30 was -$1.65.
- CIDARA THERAPEUTICS, INC. income (loss) from continuing operations, per basic share for the quarter ending 2025-03-31 was -$1.66.
- CIDARA THERAPEUTICS, INC. income (loss) from continuing operations, per basic share for the quarter ending 2024-09-30 was -$2.38.
- CIDARA THERAPEUTICS, INC. income (loss) from continuing operations, per basic share for fiscal 2024 was -$26.82.
- CIDARA THERAPEUTICS, INC. income (loss) from continuing operations, per basic share for fiscal 2023 was -$5.74.
| Period end | Income (Loss) from Continuing Operations, Per Basic Share 3 month | Income (Loss) from Continuing Operations, Per Basic Share 6 month | Income (Loss) from Continuing Operations, Per Basic Share 9 month | Income (Loss) from Continuing Operations, Per Basic Share 12 month |
|---|---|---|---|---|
| 2025-09-30 | -$3.10 10-Q · filed 2025-11-06 | -$7.00 10-Q · filed 2025-11-06 | ||
| 2025-06-30 | -$1.65 10-Q · filed 2025-08-07 | -$3.31 10-Q · filed 2025-08-07 | ||
| 2025-03-31 | -$1.66 10-Q · filed 2025-05-08 | |||
| 2024-12-31 | -$26.82 10-K · filed 2025-03-06 | |||
| 2024-09-30 | -$2.38 10-Q · filed 2025-11-06 | -$22.61 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | -$20.65 10-Q · filed 2025-08-07 | -$22.50 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | -$1.80 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | -$5.74 10-K · filed 2025-03-06 | |||
| 2023-09-30 | -$0.85 10-Q · filed 2024-11-07 | -$3.91 10-Q · filed 2024-11-07 | ||
| 2023-06-30 | -$1.37 10-Q · filed 2024-08-13 | -$3.10 10-Q · filed 2024-08-13 |